secwatch.observer — SEC 8-K summary
======================================

Issuer:     ZyVersa Therapeutics, Inc. (ZVSA)
CIK:        0001859007
Form:       8-K
Filed at:   2025-07-16T23:59:59+00:00
Accession:  0001641172-25-019856
Event type: regulatory
Sentiment:  negative
Materiality: 0.85
Item codes: 3.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

ZyVersa Therapeutics receives Nasdaq delisting notice; trading suspended July 17
--------------------------------------------------------------------------------

- Nasdaq Hearings Panel denied request to continue listing on the Nasdaq Capital Market.
- Common stock trading suspended at open on July 17, 2025; plans to trade on OTC Pink Limited Market.
- Delisting stems from non-compliance with minimum bid price requirement under Rule 5550(a)(2).
- Company may request review by Nasdaq Council within 15 days of Panel decision.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1859007/000164117225019856/0001641172-25-019856-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1859007/000164117225019856/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001641172-25-019856

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer